KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) EBT Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.33%
Dec 31, 2025 -4.21%
Sep 30, 2025 12.19%
Jun 30, 2025 -5.03%
Mar 31, 2025 -0.47%
Dec 31, 2024 -16.98%
Sep 30, 2024 6.37%
Jun 30, 2024 -20.90%
Mar 31, 2024 -15.21%
Dec 31, 2023 -17.17%
Sep 30, 2023 -1.45%
Jun 30, 2023 -9.42%
Mar 31, 2023 5.62%
Dec 31, 2022 -4.62%
Sep 30, 2022 0.09%
Jun 30, 2022 -9.64%
Mar 31, 2022 -7.40%
Dec 31, 2021 -1.37%
Sep 30, 2021 -2.28%
Jun 30, 2021 -24.02%
Mar 31, 2021 -3.83%
Dec 31, 2020 -0.38%
Sep 30, 2020 0.13%
Jun 30, 2020 0.33%
Mar 31, 2020 1.49%
Dec 31, 2019 9.05%
Sep 30, 2019 11.24%
Jun 30, 2019 7.84%
Mar 31, 2019 13.96%
Dec 31, 2018 16.60%
Sep 30, 2018 6.86%
Jun 30, 2018 13.51%
Mar 31, 2018 14.29%
Dec 31, 2017 19.12%
Sep 30, 2017 13.52%
Jun 30, 2017 11.77%
Mar 31, 2017 12.49%
Dec 31, 2016 16.78%
Sep 30, 2016 39.73%
Jun 30, 2016 10.48%
Mar 31, 2016 11.57%
Dec 31, 2015 13.88%
Sep 30, 2015 8.86%
Jun 30, 2015 6.41%
Mar 31, 2015 5.73%
Dec 31, 2014 3.65%
Sep 30, 2014 -2.79%
Jun 30, 2014 5.31%
Mar 31, 2014 -0.46%